Home › NDC Lookup › RxCUI directory › RxCUI 2637347

2 ML secukinumab 150 MG/ML Auto-Injector — RxCUI 2637347

Name: 2 ML secukinumab 150 MG/ML Auto-Injector (RxCUI 2637347)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2637347 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2637347

Official name2 ML secukinumab 150 MG/ML Auto-Injector

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known assecukinumab 300 MG per 2 ML Auto-Injector; secukinumab 300 MG in 2 ML Auto-Injector

FDA products mapped4

Package NDCs mapped9

Reported Medicaid activity (SDUD)149,840 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Secukinumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Cosentyx is a biologic injection approved for several inflammatory conditions: moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic ax...
What exactly is Cosentyx used for — and is it right for me?
Most people take Cosentyx as a subcutaneous injection — meaning a small shot under the skin, usually in the thigh, abdomen, or upper arm. You'll typically start with weekly injecti...
How do I take Cosentyx, and can I do it myself at home?

📖 Read our full Secukinumab Injection guide →

🕸️ Concept Web — How 2 ML secukinumab 150 MG/ML Auto-Injector Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 2 ML secukinumab 150 MG/ML Auto-Injector RxCUI 2637347 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Secukinumab 1599788 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Cosentyx 1599793 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Secukinumab Auto-Injector 1653240 SCDF
- Secukinumab Injectable Product 1599790 SCDG
- Secukinumab Auto-Injector [Cosentyx] 1653242 SBDF
- Cosentyx Injectable Product 1599796 SBDG
- Auto-Injector 1649570 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Secukinumab 150 MG/ML 1599789 SCDC
- 2 ML secukinumab 150 MG/ML Auto-Injector [Cosentyx] 2637348 SBD
- Secukinumab 150 MG/ML [Cosentyx] 1599794 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Secukinumab 150 MG/ML SCDC · 1599789
Secukinumab Auto-Injector SCDF · 1653240
Secukinumab Injectable Product SCDG · 1599790

Brand-Name Concepts

2 ML secukinumab 150 MG/ML Auto-Injector [Cosentyx] SBD · 2637348
Secukinumab 150 MG/ML [Cosentyx] SBDC · 1599794
Secukinumab Auto-Injector [Cosentyx] SBDF · 1653242
Cosentyx Injectable Product SBDG · 1599796
Cosentyx BN · 1599793

📦 FDA Products & Package NDCs

4 products · 9 package NDCs

9 package NDCs map to RxCUI 2637347 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00078-0639-41	2 mL in 1 CARTON (0078-0639-41)	COSENTYX	Novartis Pharmaceuticals Corporation	2015-01-21
00078-0639-68	1 mL in 1 CARTON (0078-0639-68)	COSENTYX	Novartis Pharmaceuticals Corporation	2015-01-21
00078-0639-97	1 mL in 1 CARTON (0078-0639-97)	COSENTYX	Novartis Pharmaceuticals Corporation	2015-01-21
00078-0639-98	2 mL in 1 CARTON (0078-0639-98)	COSENTYX	Novartis Pharmaceuticals Corporation	2015-01-21
00078-1056-97	1 SYRINGE, GLASS in 1 CARTON (0078-1056-97) / .5 mL in 1 SY...	COSENTYX	Novartis Pharmaceuticals Corporation	2021-05-28
00078-1056-99	1 SYRINGE, GLASS in 1 CARTON (0078-1056-99) / .5 mL in 1 SY...	COSENTYX	Novartis Pharmaceuticals Corporation	2021-05-28
00078-1070-68	1 SYRINGE, GLASS in 1 CARTON (0078-1070-68) / 2 mL in 1 SYR...	COSENTYX	Novartis Pharmaceuticals Corporation	2023-05-11
00078-1070-96	1 SYRINGE, GLASS in 1 CARTON (0078-1070-96) / 2 mL in 1 SYR...	COSENTYX	Novartis Pharmaceuticals Corporation	2023-05-11
00078-1168-61	5 mL in 1 VIAL, GLASS (0078-1168-61)	COSENTYX	Novartis Pharmaceuticals Corporation	2023-10-06

Observed labelers: Novartis Pharmaceuticals Corporation (9) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J3247	Inj secukinumab intrav 1mg	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.